Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Instil Bio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 77 | +14 |
| Shares | 71.9M | 1.45M | 116.1M | +45.6M (+64.8%) |
| Value | $1.28B | $25.9M | $1.99B | +$726.8M (+57.7%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Instil Bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $649.8M | 100.00% |
| Alps Advisors Inc | 149,202 | $2.55M | 0.03% |
| ProShare Advisors LLC | 29,983 | $514.0K | 0.00% |
| Rock Creek Group, LP | 34,795 | $404.0K | 0.06% |
| Invesco Ltd. | 22,249 | $381.0K | 0.00% |
| Handelsbanken Fonder AB | 22,000 | $376.0K | 0.00% |
| Voya Investment Management LLC | 18,955 | $324.0K | 0.00% |
| Wells Fargo & Company | 18,776 | $321.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 11,869 | $203.0K | 0.00% |
| Gyon Technologies Capital Management, LP | 11,810 | $202.0K | 0.04% |
| D. E. Shaw & Co., Inc. | 10,623 | $182.0K | 0.00% |
| UBS Group AG | 10,558 | $181.0K | 0.00% |
| Virtus ETF Advisers LLC | 9,327 | $160.0K | 0.06% |
| SG Americas Securities, LLC | 8,871 | $152.0K | 0.00% |
| DekaBank Deutsche Girozentrale | 8,000 | $132.0K | 0.00% |
| Lindbrook Capital, LLC | 1,370 | $23.0K | 0.00% |
| Daiwa Securities Group Inc. | 376 | $6.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 205 | $4.00K | 0.00% |
| Covestor Ltd | 29 | $0 | 0.00% |
Sold out (5)
Institutions that held Instil Bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Logos Global Management LP | 1,277,091 | $22.8M |
| Deerfield Management Company, L.P. (Series C) | 1,115,739 | $19.9M |
| Beacon Pointe Advisors, LLC | 97,799 | $1.75M |
| Ergoteles LLC | 79,911 | $1.43M |
| Balyasny Asset Management LLC | 26,387 | $472.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Instil Bio, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 1,445,867 | $25.9M |